Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine for Metabolic Syndrome (ARCH-MS)
NCT00455325Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Sep 2004
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chloroquine in metabolic syndrome, sponsored by Washington University School of Medicine. Started Sep 2004; status: completed.
02
Drugs
chloroquine
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00455325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00455325.